Qsymia Approved for Weight Management
New Drugs , News / September 30, 2016

The FDA today approved Qsymia (phentermine and topiramate extended-release) as an addition to a reduced-calorie diet and exercise for chronic weight management. Qsymia is approved for use in adults with a body mass index (BMI) of 30 or greater (ob...

Topiramate: Risk of Oral Clefts in Newborns
Drug Alerts , News / September 21, 2016

Based on data obtained from the North American Antiepileptic Drug (NAAED) Pregnancy Registry, the FDA advised healthcare professionals and patients of an increased risk of development of cleft lip and/or cleft palate (oral clefts) in infants born ...

Skip to toolbar